S100B is a calcium‐binding peptide produced mainly by astrocytes that exert paracrine and
autocrine effects on neurons and glia. Some knowledge has been acquired from in vitro and …

Purpose This review summarizes protein biomarkers in mild and severe traumatic brain
injury in adults and children and presents a strategy for conducting rationally designed …

The diagnosis of perinatal insults currently relies on adequate documentation of general
medical and obstetric factors and on radiologic and laboratory assessments. The …

We provide a critical analysis of the relevance of S100B in acute brain injury emphazising
the beneficial effect of its biological properties. S100B is a calcium-binding protein, primarily …

The detection of neuron-specific proteins in blood might allow quantification of the degree of
neuropathology in experimental and clinical contexts. We have been studying a novel blood …

We provide a critical analysis of the value of S100B as a marker of brain damage and
possible therapeutic implications. The early assessment of the injury severity and the …

Previous studies from our laboratory indicate that traumatic brain injury (TBI) in humans
results in proteolysis of neuronally-localized, intracellular microtubule associated protein …

This prospective clinical study was conducted to determine whether S 100 B is a reliable
serum marker for traumatic brain injury (TBI) with and without multiple trauma. Fifty-five …

An improved understanding and characterization of glial activation and its relationship with
white matter injury will likely serve as a novel treatment target to curb post injury …

The biological consequences of exposure to explosive blast are extremely complex. Serum
protein biomarkers in blast-induced traumatic brain injury (bTBI) can aid in determining …